Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma (Q43765815)

26 November 2017

Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma (English)

1 reference

26 November 2017

0 references

1 reference

Vlad C Sandulache

1

1 reference

26 November 2017

John S Hamblin

2

1 reference

26 November 2017

Heath D Skinner

3

1 reference

26 November 2017

Mark W Kubik

4

1 reference

26 November 2017

Jeffrey N Myers

5

1 reference

26 November 2017

Jose P Zevallos

6

1 reference

26 November 2017

29 January 2014

1 reference

26 November 2017

1 reference

26 November 2017

36

1 reference

26 November 2017

1039-1043

1 reference

26 November 2017

7

1 reference

26 November 2017

Global cancer statistics

1 reference

Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.

21 January 2018

1 reference

Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

21 January 2018

1 reference

Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck

21 January 2018

1 reference

A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.

21 January 2018

1 reference

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

A preliminary comparative study of the prognostic implications of type 2 diabetes mellitus for patients with primary gingival carcinoma treated with surgery and radiation therapy

21 January 2018

1 reference

Diabetes mellitus and cancer risk in a network of case-control studies

21 January 2018

1 reference

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

21 January 2018

1 reference

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

Metformin and neoplasia: implications and indications

21 January 2018

1 reference

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

21 January 2018

1 reference

Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.

21 January 2018

1 reference

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

21 January 2018

1 reference

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

21 January 2018

1 reference

Metformin use and improved response to therapy in rectal cancer

21 January 2018

1 reference

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

21 January 2018

1 reference

Patterns of multimorbidity in elderly veterans

21 January 2018

1 reference

Impact of race/ethnicity on laryngeal cancer in patients treated at a Veterans Affairs Medical Center.

21 January 2018

1 reference

Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems

21 January 2018

1 reference

Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions

21 January 2018

1 reference

Concurrent Cisplatin and Radiation Versus Cetuximab and Radiation for Locally Advanced Head-and-Neck Cancer

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Metformin use and improved response to therapy in esophageal adenocarcinoma

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HED.23409

1 reference

26 November 2017

1 reference